Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000677632 | SCV002204386 | pathogenic | Bailey-Bloch congenital myopathy | 2024-10-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu255Ilefs*58) in the STAC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STAC3 are known to be pathogenic (PMID: 28411587, 28777491). This variant is present in population databases (rs773050511, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with STAC3-related conditions (PMID: 28777491). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 559850). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000677632 | SCV000803761 | pathogenic | Bailey-Bloch congenital myopathy | 2024-07-16 | no assertion criteria provided | literature only | |
Gene |
RCV000677632 | SCV000994602 | not provided | Bailey-Bloch congenital myopathy | no assertion provided | literature only |